Antimicrobial resistance means the age of antibiotics – when humanity has had the luxury of fixing or preventing all manner of disease with a simple biological agent in a capsule – is coming to an end. Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham talks to Proactive’s Susanna Nelson about how we stay one step ahead in the fight against deadly pathogens and avoid the next superbug.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com